<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34335596</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention.</ArticleTitle><Pagination><StartPage>690976</StartPage><MedlinePgn>690976</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">690976</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.690976</ELocationID><Abstract><AbstractText>Different emerging viral infections may emerge in different regions of the world and pose a global pandemic threat with high fatality. Clarification of the immunopathogenesis of different emerging viral infections can provide a plan for the crisis management and prevention of emerging infections. This perspective article describes how an emerging viral infection evolves from microbial mutation, zoonotic and/or vector-borne transmission that progresses to a fatal infection due to overt viremia, tissue-specific cytotropic damage or/and immunopathology. We classified immunopathogenesis of common emerging viral infections into 4 categories: 1) deficient immunity with disseminated viremia (e.g., Ebola); 2) pneumocytotropism with/without later hyperinflammation (e.g., COVID-19); 3)&#xa0;augmented immunopathology (e.g., Hanta); and 4) antibody-dependent enhancement of infection with altered immunity (e.g., Dengue). A practical guide to early blocking of viral evasion, limiting viral load and identifying the fatal mechanism of an emerging viral infection is provided to prevent and reduce the transmission, and to do rapid diagnoses followed by the early treatment of virus neutralization for reduction of morbidity and mortality of an emerging viral infection such as COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Yang and Yang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Betsy</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Kaiser Permanente Oakland Medical Center, Oakland, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Kuender D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>DIvision of Medical Research, Mackay Children's Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, National Defense Medical Center, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019067" MajorTopicYN="N">Antibody-Dependent Enhancement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057131" MajorTopicYN="N">Immune Evasion</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">early diagnosis</Keyword><Keyword MajorTopicYN="N">early treatment</Keyword><Keyword MajorTopicYN="N">emerging viral infections</Keyword><Keyword MajorTopicYN="N">evasion</Keyword><Keyword MajorTopicYN="N">fatality</Keyword><Keyword MajorTopicYN="N">immunopathogenesis</Keyword><Keyword MajorTopicYN="N">prevention</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>2</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34335596</ArticleId><ArticleId IdType="pmc">PMC8320726</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.690976</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hui EK. Reasons for the Increase in Emerging and Re-Emerging Viral Infectious Diseases. Microbes Infect (2006) 8:905&#x2013;16. &#xa0;10.1016/j.micinf.2005.06.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2005.06.032</ArticleId><ArticleId IdType="pmc">PMC7110580</ArticleId><ArticleId IdType="pubmed">16448839</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark LK, Green TJ, Petit CM. Structure of Nonstructural Protein 1 From SARS-Cov-2. J Virol (2021) 95(4):e02019&#x2013;20. &#xa0;10.1101/2020.11.03.366757</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.03.366757</ArticleId><ArticleId IdType="pmc">PMC7851544</ArticleId><ArticleId IdType="pubmed">33234675</ArticleId></ArticleIdList></Reference><Reference><Citation>Jester BJ, Uyeki TM, Jernigan DB. Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968. Am J Public Health (2020) 110(5):669&#x2013;76. &#xa0;10.2105/AJPH.2019.305557</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2019.305557</ArticleId><ArticleId IdType="pmc">PMC7144439</ArticleId><ArticleId IdType="pubmed">32267748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowen A, Palese P. Transmission of Influenza Virus in Temperate Zones is Predominantly by Aerosol, in the Tropics by Contact: A Hypothesis. PloS Curr (2009) 1:RRN1002. &#xa0;10.1371/currents.rrn1002</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/currents.rrn1002</ArticleId><ArticleId IdType="pmc">PMC2762697</ArticleId><ArticleId IdType="pubmed">20025197</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips ML. Dengue Reborn: Widespread Resurgence of a Resilient Vector. Environ Health Perspect (2008) 116:A382&#x2013;8. &#xa0;10.1289/ehp.116-a382</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.116-a382</ArticleId><ArticleId IdType="pmc">PMC2535648</ArticleId><ArticleId IdType="pubmed">18795135</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson B, Chambers TV, Crabtree MB, Filippis AM, Vilarinhos PT, Resende MC, et al. . Vector Competence of Brazilian Aedes Aegypti and Ae. Albopictus for a Brazilian Yellow Fever Virus Isolate. Trans R Soc Trop Med Hyg (2002) 96:611&#x2013;3. &#xa0;10.1016/s0035-9203(02)90326-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0035-9203(02)90326-3</ArticleId><ArticleId IdType="pubmed">12625133</ArticleId></ArticleIdList></Reference><Reference><Citation>Brault AC. Changing Patterns of West Nile Virus Transmission: Altered Vector Competence and Host Susceptibility. Vet Res (2009) 40:43. &#xa0;10.1051/vetres/2009026</Citation><ArticleIdList><ArticleId IdType="doi">10.1051/vetres/2009026</ArticleId><ArticleId IdType="pmc">PMC2695027</ArticleId><ArticleId IdType="pubmed">19406093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeier M, Handermann M, Bahr U, Rensch B, M&#xfc;ller S, Kehm R, et al. . New Ecological Aspects of Hantavirus Infection: A Change of a Paradigm and a Challenge of Prevention&#x2013;a Review. Virus Genes (2005) 30:157&#x2013;80. &#xa0;10.1007/s11262-004-5625-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-004-5625-2</ArticleId><ArticleId IdType="pubmed">15744574</ArticleId></ArticleIdList></Reference><Reference><Citation>Chae JS, Adjemian JZ, Kim HC, Ko S, Klein TA, Foley J. Predicting the Emergence of Tick-Borne Infections Based on Climatic Changes in Korea. Vector Borne Zoonotic Dis (2008) 8:265&#x2013;75. &#xa0;10.1089/vbz.2007.0190</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vbz.2007.0190</ArticleId><ArticleId IdType="pubmed">18429692</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YZ, Dong X, Li X, Ma C, Xiong HP, Yan GJ, et al. . Seoul Virus and Hantavirus Disease, Shenyang, People&#x2019;s Republic of China. Emerg Infect Dis (2009) 15:200&#x2013;6. &#xa0;10.3201/eid1502.080291</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1502.080291</ArticleId><ArticleId IdType="pmc">PMC2662651</ArticleId><ArticleId IdType="pubmed">19193263</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M, Seifert SN, Olival KJ, Plowright RK, Munster VJ. Bat-Borne Virus Diversity, Spillover and Emergence. Nat Rev Microbiol (2020) 18(8):461&#x2013;71. &#xa0;10.1038/s41579-020-0394-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-0394-z</ArticleId><ArticleId IdType="pmc">PMC7289071</ArticleId><ArticleId IdType="pubmed">32528128</ArticleId></ArticleIdList></Reference><Reference><Citation>Leffel EK, Reed DS. Marburg and Ebola Viruses as Aerosol Threats. Biosecur Bioterror (2004) 2:186&#x2013;91. &#xa0;10.1089/bsp.2004.2.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/bsp.2004.2.186</ArticleId><ArticleId IdType="pubmed">15588056</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo E, Holland JJ. RNA Virus Mutations and Fitness for Survival. Ann Rev Microbiol (1997) 51:151&#x2013;78. &#xa0;10.1146/annurev.micro.51.1.151</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.51.1.151</ArticleId><ArticleId IdType="pubmed">9343347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanju&#xe1;n R, Domingo-Calap P. Mechanisms of Viral Mutatio. Cell Mol Life Sci (2016) 73:4433&#x2013;48. &#xa0;10.1007/s00018-016-2299-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-016-2299-6</ArticleId><ArticleId IdType="pmc">PMC5075021</ArticleId><ArticleId IdType="pubmed">27392606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedford T, Riley S, Barr IG, Broor S, Chadha M, et al. . Global Circulation Patterns of Seasonal Influenza Viruses Vary With Antigenic Drift. Nature (2015) 523:217&#x2013;20. &#xa0;10.1038/nature14460</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14460</ArticleId><ArticleId IdType="pmc">PMC4499780</ArticleId><ArticleId IdType="pubmed">26053121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen HL, Si LY, Yuan XJ, Hao SB, Gao F, Chu F, et al. . Complete Genome Sequencing and Analysis of Six Enterovirus 71 Strains With Different Clinical Phenotypes. Virol J (2013) 10:115. &#xa0;10.1186/1743-422X-10-115</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-115</ArticleId><ArticleId IdType="pmc">PMC3669102</ArticleId><ArticleId IdType="pubmed">23577963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CK, Wu SR, Chen YC, Lee KJ, Chung NH, Lu YJ, et al. . Mutations in VP1 and 5&#x2019;-UTR Affect Enterovirus 71 Virulence. Sci Rep (2018) 8:6688. &#xa0;10.1038/s41598-018-25091-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25091-7</ArticleId><ArticleId IdType="pmc">PMC5923339</ArticleId><ArticleId IdType="pubmed">29703921</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh SH, Wang HY, Tsai CY, Kao CL, Yang JY, Liu HW, et al. . Characterization of Severe Acute Respiratory Syndrome Coronavirus Genomes in Taiwan: Molecular Epidemiology and Genome Evolution. Proc Natl Acad Sci U S A (2004) 101:2542&#x2013;7. &#xa0;10.1073/pnas.0307904100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0307904100</ArticleId><ArticleId IdType="pmc">PMC356986</ArticleId><ArticleId IdType="pubmed">14983045</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercatelli D, Giorgi FM. Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Front Microbiol (2020) 11:1800. &#xa0;10.3389/fmicb.2020.01800</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01800</ArticleId><ArticleId IdType="pmc">PMC7387429</ArticleId><ArticleId IdType="pubmed">32793182</ArticleId></ArticleIdList></Reference><Reference><Citation>
Wikipedia . Variants of SASR-CoV-2. Retrieved on May, 26, 2021 (2021). Available at: https://en.wikipedia.org/wiki/Variants_of_SARS-CoV-2#cite_note-28.</Citation></Reference><Reference><Citation>Graham MS, Sudre CH, May A, Antonelli M, Murray B, Varsavsky T, et al. . Changes in Symptomatology, Reinfection, and Transmissibility Associated With the SARS-CoV-2 Variant B.1.1.7: An Ecological Study. Lancet Public Health (2021) 6(5):e335&#x2013;45.&#xa0;10.1016/S2468-2667(21)00055-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00055-4</ArticleId><ArticleId IdType="pmc">PMC8041365</ArticleId><ArticleId IdType="pubmed">33857453</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas D, Bruel T, Grzelak L, Guivel-Benhassine F, Staropoli I, et al. . Sensitivity of Infectious SARS-CoV-2 B.1.1.7 and B.1.351 Variants to Neutralizing Antibodies. Nat Med (2021) 27(5):917&#x2013;24. &#xa0;10.1038/s41591-021-01318-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01318-5</ArticleId><ArticleId IdType="pubmed">33772244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacisuleyman E, Hale C, Saito Y, Blachere NE, Bergh M, Porrot F, et al. . Vaccine Breakthrough Infections With SARS-CoV-2 Variants. N Engl J Med (2021) NEJMoa2105000. &#xa0;10.1056/NEJMoa2105000</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2105000</ArticleId><ArticleId IdType="pmc">PMC8117968</ArticleId><ArticleId IdType="pubmed">33882219</ArticleId></ArticleIdList></Reference><Reference><Citation>He CQ, He M, He HB, Wang HM, Ding NZ. The Matrix Segment of the &#x201c;Spanish Fl&#x201d; Virus Originated From Intragenic Recombination Between Avian and Human Influenza A Viruses. Transbound Emerg Dis (2019) 66:2188&#x2013;95. &#xa0;10.1111/tbed.13282</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tbed.13282</ArticleId><ArticleId IdType="pmc">PMC7168540</ArticleId><ArticleId IdType="pubmed">31241237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumlin U, Olofsson S, Dimock K, Arnberg N. Sialic Acid Tissue Distribution and Influenza Virus Tropism. Influenza Other Respir Viruses (2008) 2:147&#x2013;54. &#xa0;10.1111/j.1750-2659.2008.00051.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-2659.2008.00051.x</ArticleId><ArticleId IdType="pmc">PMC4941897</ArticleId><ArticleId IdType="pubmed">19453419</ArticleId></ArticleIdList></Reference><Reference><Citation>Essere B, Yver M, Gavazzi C, Terrier O, Isel C, Fournier E, et al. . Critical Role of Segment-Specific Packaging Signals in Genetic Reassortment of Influenza A Viruses. Proc Natl Acad Sci U S A (2013) 110:E3840&#x2013;8. &#xa0;10.1073/pnas.1308649110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1308649110</ArticleId><ArticleId IdType="pmc">PMC3791739</ArticleId><ArticleId IdType="pubmed">24043788</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EC, Denison MR. Coronaviruses as DNA Wannabes: A New Model for the Regulation of RNA Virus Replication Fidelity. PloS Pathog (2013) 9:e1003760. &#xa0;10.1371/journal.ppat.1003760</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003760</ArticleId><ArticleId IdType="pmc">PMC3857799</ArticleId><ArticleId IdType="pubmed">24348241</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagliani R, Forni D, Clerici M, Sironi M. Computational Inference of Selection Underlying the Evolution of the Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2. J Virol (2020) 94:e00411&#x2013;20. &#xa0;10.1128/JVI.00411-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00411-20</ArticleId><ArticleId IdType="pmc">PMC7307108</ArticleId><ArticleId IdType="pubmed">32238584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd HA, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Origin and Animal Reservoir. Virol J (2016) 13:87. &#xa0;10.1186/s12985-016-0544-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0544-0</ArticleId><ArticleId IdType="pmc">PMC4891877</ArticleId><ArticleId IdType="pubmed">27255185</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. . Isolation and Characterization of Viruses Related to the SARS Coronavirus From Animals in Southern China. Science (2003) 302:276&#x2013;8. &#xa0;10.1126/science.1087139</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1087139</ArticleId><ArticleId IdType="pubmed">12958366</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Giorgi EE, Marichann MH, Foley B, Xiao C, Kong XP, et al. . Emergence of SARS-CoV-2 Through Recombination and Strong Purifying Selection. Sci Adv (2020) 6:eabb9153. &#xa0;10.1126/sciadv.abb9153</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abb9153</ArticleId><ArticleId IdType="pmc">PMC7458444</ArticleId><ArticleId IdType="pubmed">32937441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu Z, Meng K, Meng G. Genomic Recombination Events may Reveal the Evolution of Coronavirus and the Origin of SARS-Cov-2. Sci Rep (2020) 10(1):21617. &#xa0;10.1038/s41598-020-78703-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78703-6</ArticleId><ArticleId IdType="pmc">PMC7728743</ArticleId><ArticleId IdType="pubmed">33303849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Shen L, Gu X. Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission. Sci Rep (2016) 6:25049. &#xa0;10.1038/srep25049</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep25049</ArticleId><ArticleId IdType="pmc">PMC4855236</ArticleId><ArticleId IdType="pubmed">27142087</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong YN, Tsao KC, Hsiao MJ, Huang CG, Huang PN, Huang PW, et al. . Sars-CoV-2 Genomic Surveillance in Taiwan Revealed Novel ORF8-Deletion Mutant and Clade Possibly Associated With Infections in Middle East. Emerg Microb Infect (2020) 9:1457&#x2013;66. &#xa0;10.1080/22221751.2020.1782271</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1782271</ArticleId><ArticleId IdType="pmc">PMC7473175</ArticleId><ArticleId IdType="pubmed">32543353</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza Trindade G, da Fonseca FG, Marques JT, Lacerda Nogueira M, Nogueira Mendes LC, Secorun Borges A, et al. . Ara&#xe7;atuba Virus: A Vaccinia Like Virus Associated With Infection in Humans and Cattle. Emerg Infect Dis (2003) 9:155&#x2013;60. &#xa0;10.3201/eid0902.020244</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0902.020244</ArticleId><ArticleId IdType="pmc">PMC2901946</ArticleId><ArticleId IdType="pubmed">12603984</ArticleId></ArticleIdList></Reference><Reference><Citation>Damaso CR, Reis SA, Jesus DM, Lima PS, Moussatch&#xe9; N. A PCR-Based Assay for Detection of Emerging Vaccinia-Like Viruses Isolated in Brazil. Diagn Microbiol Infect Dis (2007) 57(1):39&#x2013;46. &#xa0;10.1016/j.diagmicrobio.2006.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2006.07.012</ArticleId><ArticleId IdType="pubmed">16949244</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowen AC, Steel J, Mubareka S, Palese P. High Temperature (30&#xb0;C) Blocks Aerosol But Not Contact Transmission of Influenza Virus. J Virol (2008) 82:5650&#x2013;2. &#xa0;10.1128/JVI.00325-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00325-08</ArticleId><ArticleId IdType="pmc">PMC2395183</ArticleId><ArticleId IdType="pubmed">18367530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ. Identifying Airborne Transmission as the Dominant Route for the Spread of COVID-19. Proc&#xa0;Natl Acad Sci USA (2020) 117:14857&#x2013;63. &#xa0;10.1073/pnas.2009637117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009637117</ArticleId><ArticleId IdType="pmc">PMC7334447</ArticleId><ArticleId IdType="pubmed">32527856</ArticleId></ArticleIdList></Reference><Reference><Citation>Servadio JL, Rosenthal SR, Carlson L, Bauer C. Climate Patterns and Mosquito-Borne Disease Outbreaks in South and Southeast Asia. J Infect Public Health (2018) 11:566&#x2013;71. &#xa0;10.1016/j.jiph.2017.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2017.12.006</ArticleId><ArticleId IdType="pubmed">29274851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotsakiozi P, Evans BR, Gloria-Soria A, Kamgang B, Mayanja M, Lutwama J, et al. . Population Structure of a Vector of Human Diseases: Aedes Aegypti in its Ancestral Range, Africa. Ecol Evol (2018) 8:7835&#x2013;48. &#xa0;10.1002/ece3.4278</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ece3.4278</ArticleId><ArticleId IdType="pmc">PMC6145026</ArticleId><ArticleId IdType="pubmed">30250667</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell JR. Mosquitoes on the Move. Science (2016) 354:971&#x2013;2. &#xa0;10.1126/science.aal1717</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aal1717</ArticleId><ArticleId IdType="pubmed">27884993</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . Dengue and Severe Dengue. Retrieved on March 13, 2021 (2020). Available at: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.</Citation></Reference><Reference><Citation>Halstead S. Recent Advances in Understanding Dengue. F1000Res (2019) 8:F1000 Faculty Rev&#x2013;1279. &#xa0;10.12688/f1000research.19197.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.19197.1</ArticleId><ArticleId IdType="pmc">PMC6676504</ArticleId><ArticleId IdType="pubmed">31448083</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Liu J, Du S, Shan C, Nie K, Zhang R, et al. . Evolutionary Enhancement of Zika Virus Infectivity in Aedes Aegypti Mosquitoes. Nature (2017) 545:482&#x2013;6. &#xa0;10.1038/nature22365</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22365</ArticleId><ArticleId IdType="pmc">PMC5885636</ArticleId><ArticleId IdType="pubmed">28514450</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt DJ, Miner JJ. Consequences of Congenital Zika Virus Infection. Curr Opin Virol (2017) 27:1&#x2013;7. &#xa0;10.1016/j.coviro.2017.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.09.005</ArticleId><ArticleId IdType="pmc">PMC5814142</ArticleId><ArticleId IdType="pubmed">29080429</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner CL, Ryman KD. Yellow Fever: A Reemerging Threat. Clin Lab Med (2010) 30:237&#x2013;60. &#xa0;10.1016/j.cll.2010.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2010.01.001</ArticleId><ArticleId IdType="pmc">PMC4349381</ArticleId><ArticleId IdType="pubmed">20513550</ArticleId></ArticleIdList></Reference><Reference><Citation>Douam F, Ploss A. Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe. Trends Microbiol (2018) 26:913&#x2013;28. &#xa0;10.1016/j.tim.2018.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2018.05.012</ArticleId><ArticleId IdType="pmc">PMC6340642</ArticleId><ArticleId IdType="pubmed">29933925</ArticleId></ArticleIdList></Reference><Reference><Citation>Roehrig JT. West Nile Virus in the United States -&#xa0;a Historical Perspective. Viruses (2013) 5:3088&#x2013;108. &#xa0;10.3390/v5123088</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v5123088</ArticleId><ArticleId IdType="pmc">PMC3967162</ArticleId><ArticleId IdType="pubmed">24335779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J, Brito AF, Swetnam DM, Vogels CBF, Tokarz RE, Andersen KG, et al. . Twenty Years of West Nile Virus Spread and Evolution in the Americas Visualized by Nextstrain. PloS Pathog (2019) 15:e1008042. &#xa0;10.1371/journal.ppat.1008042</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008042</ArticleId><ArticleId IdType="pmc">PMC6822705</ArticleId><ArticleId IdType="pubmed">31671157</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ. Clinical Manifestations and Outcomes of West Nile Virus Infection. Viruses (2014) 6:606&#x2013;23. &#xa0;10.3390/v6020606</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3939474</ArticleId><ArticleId IdType="pubmed">24509812</ArticleId></ArticleIdList></Reference><Reference><Citation>Filgueira L, Lannes N. Review of Emerging Japanese Encephalitis Virus: New Aspects and Concepts About Entry Into the Brain and Inter-Cellular Spreading. Pathogens (2019) 8:111. &#xa0;10.3390/pathogens8030111</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens8030111</ArticleId><ArticleId IdType="pmc">PMC6789543</ArticleId><ArticleId IdType="pubmed">31357540</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wispelaere M, Despr&#xe8;s P, Choumet V. European Aedes Albopictus and Culex Pipiens are Competent Vectors for Japanese Encephalitis Virus. PloS Negl Trop Dis (2017) 11:e0005294. &#xa0;10.1371/journal.pntd.0005294</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005294</ArticleId><ArticleId IdType="pmc">PMC5268654</ArticleId><ArticleId IdType="pubmed">28085881</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YZ, Zou Y, Fu ZF, Plyusnin A. Hantavirus Infections in Humans and Animals, China. Emerg Infect Dis (2010) 16:1195&#x2013;203. &#xa0;10.3201/eid1608.090470</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1608.090470</ArticleId><ArticleId IdType="pmc">PMC3298307</ArticleId><ArticleId IdType="pubmed">20678311</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira SV, Faccini-Mart&#xed;nez &#xc1;A. Hantavirus Infection and the Renal Syndrom. In: Bezerra da Silva Junior G, De Francesco Daher E, Barros E, editors. Tropical Nephrology (2020) 175&#x2013;92. &#xa0;10.1007/978-3-030-44500-3_14</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-44500-3_14</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement J, LeDuc JW, Lloyd G, Reynes JM, McElhinney L, Van Ranst M, et al. . Wild Rats, Laboratory Rats, Pet Rats: Global Seoul Hantavirus Disease Revisited. Viruses (2019) 11:652. &#xa0;10.3390/v11070652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070652</ArticleId><ArticleId IdType="pmc">PMC6669632</ArticleId><ArticleId IdType="pubmed">31319534</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez R, P&#xe9;rez-Araos R, Salazar &#xc1;, Ulloa AL, Vial C, Vial PA, et al. . Hemodynamic and Pulmonary Permeability Characterization of Hantavirus Cardiopulmonary Syndrome by Transpulmonary Thermodilution. Viruses (2019) 11:900. &#xa0;10.3390/v11100900</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11100900</ArticleId><ArticleId IdType="pmc">PMC6832621</ArticleId><ArticleId IdType="pubmed">31569646</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke CB. Population Diversity and Collective Interactions During Influenza Virus Infection. J Virol (2017) 91:e01164&#x2013;17. &#xa0;10.1128/JVI.01164-17</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01164-17</ArticleId><ArticleId IdType="pmc">PMC5660503</ArticleId><ArticleId IdType="pubmed">28855247</ArticleId></ArticleIdList></Reference><Reference><Citation>Morans DM, Taubenberger JK. Influenza: The Once and Future Pandemic. Public Health Rep (2010) 125(Suppl 3):16&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2862331</ArticleId><ArticleId IdType="pubmed">20568566</ArticleId></ArticleIdList></Reference><Reference><Citation>Taubenberger JK, Kash JC. Influenza Virus Evolution, Host Adaptation and Pandemic Formation. Cell Host Microbe (2010) 7:440&#x2013;51. &#xa0;10.1016/j.chom.2010.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.05.009</ArticleId><ArticleId IdType="pmc">PMC2892379</ArticleId><ArticleId IdType="pubmed">20542248</ArticleId></ArticleIdList></Reference><Reference><Citation>Reperant LA, Moesker FM, Osterhaus ADME. Influenza: From Zoonosis to Pandemic. ERJ Open Res (2016) 2(1):00013&#x2013;2016. &#xa0;10.1183/23120541.00013-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00013-2016</ArticleId><ArticleId IdType="pmc">PMC5005146</ArticleId><ArticleId IdType="pubmed">27730163</ArticleId></ArticleIdList></Reference><Reference><Citation>Biggerstaff M, Cauchemez S, Reed C, Gambhir M, Finelli L. Estimates of the Reproduction Number for Seasonal, Pandemic, and Zoonotic Influenza: A Systematic Review of the Literature. BMC Infect Dis (2014) 14:480.&#xa0;10.1186/1471-2334-14-480</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-480</ArticleId><ArticleId IdType="pmc">PMC4169819</ArticleId><ArticleId IdType="pubmed">25186370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the Reproductive Number of Novel Coronavirus (COVID-19) and the Probable Outbreak Size on the Diamond Princess Cruise Ship: A Data-Driven Analysis. Int J Infect Dis (2020) 93:201&#x2013;4. &#xa0;10.1016/j.ijid.2020.02.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.02.033</ArticleId><ArticleId IdType="pmc">PMC7110591</ArticleId><ArticleId IdType="pubmed">32097725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HJ. Estimation of Basic Reproduction Number of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) During the Outbreak in South Korea, 2015. Biomed Eng Online (2017) 16(1):79. &#xa0;10.1186/s12938-017-0370-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12938-017-0370-7</ArticleId><ArticleId IdType="pmc">PMC5470331</ArticleId><ArticleId IdType="pubmed">28610609</ArticleId></ArticleIdList></Reference><Reference><Citation>
D&#x2019;Souza GA, Dowdy D. What is Herd Immunity and How can We Achieve it With COVID-19?
Johns Hopkins Bloomberg School of Public Health;  (2020). (10 April 2020). Available at: https://www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html.</Citation></Reference><Reference><Citation>Puissant B, Roubinet F, Massip P, Sandres-Saune K, Apoil PA, et al. . Analysis of CCR5, CCR2, CX3CR1, and SDF1 Polymorphisms in HIV-Positive Treated Patients: Impact on Response to HAART and on Peripheral T Lymphocyte Counts. AIDS Res Hum Retroviruses (2006) 22:153&#x2013;62. &#xa0;10.1089/aid.2006.22.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.2006.22.153</ArticleId><ArticleId IdType="pubmed">16478397</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S, Alagarasu K, Selvaraj P. Immunogenetics of HIV and HIV Associated Tuberculosis. Tuberculosis (Edinb) (2012) 92:18&#x2013;30. &#xa0;10.1016/j.tube.2011.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tube.2011.08.004</ArticleId><ArticleId IdType="pubmed">21943869</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, Wang L, Cheng JT, Chuang H, Chang JC, Liu JW, et al. . Combination of CTLA-4 and TGFbeta1 Gene Polymorphisms Associated With Dengue Hemorrhagic Fever and Virus Load in a Dengue-2 Outbreak. Clin Immunol (2009) 131:404&#x2013;9. &#xa0;10.1016/j.clim.2009.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2009.01.015</ArticleId><ArticleId IdType="pubmed">19269255</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Chang WP, Wang L, Lin YJ, Liang CD, Kuo HC, et al. . Dc-SIGN (Cd209) Promoter -336 a/G Polymorphism Is Associated With Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation. PloS Negl Trop Dis (2011) 5:e934. &#xa0;10.1371/journal.pntd.0000934</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000934</ArticleId><ArticleId IdType="pmc">PMC3014977</ArticleId><ArticleId IdType="pubmed">21245921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakuntabhai A, Turbpaiboon C, Casad&#xe9;mont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, et al. . A Variant in the CD209 Promoter Is Associated With Severity of Dengue Disease. Nat Genet (2005) 37:507&#x2013;13. &#xa0;10.1038/ng1550</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1550</ArticleId><ArticleId IdType="pmc">PMC7096904</ArticleId><ArticleId IdType="pubmed">15838506</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Li Q, Ye H, Zhang Q, Chen H, Huang F, et al. . The Nine-Repeat DC-SIGNR Isoform Is Associated With Increased HIV-RNA Loads and HIV Sexual Transmission. J Clin Immunol (2010) 30:402&#x2013;7. &#xa0;10.1007/s10875-010-9376-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-010-9376-7</ArticleId><ArticleId IdType="pubmed">20217198</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu RW, Tang NL, Hui DS, Chung GT, Chim SS, Chan KCA, et al. . ACE2 Gene Polymorphisms Do Not Affect Outcome of Severe Acute Respiratory Syndrome. Clin Chem (2004) 50:1683&#x2013;6. &#xa0;10.1373/clinchem.2004.035436</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2004.035436</ArticleId><ArticleId IdType="pmc">PMC7108155</ArticleId><ArticleId IdType="pubmed">15331509</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant OC, Montgomery D, Ito K, Woods RJ. Analysis of the SARS-CoV-2 Spike Protein Glycan Shield Reveals Implications for Immune Recognition. Sci Rep (2020) 10:14991. &#xa0;10.1038/s41598-020-71748-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-71748-7</ArticleId><ArticleId IdType="pmc">PMC7490396</ArticleId><ArticleId IdType="pubmed">32929138</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Tian X, Qi R, Peng C, Zhang W. Identification of 22 N-Glycosites on Spike Glycoprotein of SARS-CoV-2 and Accessible Surface Glycopeptide Motifs: Implications for Vaccination and Antibody Therapeutics. Glycobiology (2020) 2020:cwaa052. &#xa0;10.1093/glycob/cwaa052</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwaa052</ArticleId><ArticleId IdType="pmc">PMC7313968</ArticleId><ArticleId IdType="pubmed">32518941</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Made CI, Simons A, Schuurs-Hoeijmakers J, van den Heuvel G, Mantere T, Kersten S, et al. . Presence of Genetic Variants Among Young Men With Severe COVID-19. JAMA (2020) 324:663&#x2013;73. &#xa0;10.1001/jama.2020.13719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13719</ArticleId><ArticleId IdType="pmc">PMC7382021</ArticleId><ArticleId IdType="pubmed">32706371</ArticleId></ArticleIdList></Reference><Reference><Citation>Avenda&#xf1;o-Tamayo E, R&#xfa;a A, Parra-Mar&#xed;n MV, Rojas W, Campo O, Agudelo-Fl&#xf3;rez P, et al. . Evaluation of Variants in IL6R, TLR3, and DC-SIGN Genes Associated With Dengue in Sampled Colombian Population. Biomedica (2019) 39:88&#x2013;101. &#xa0;10.7705/biomedica.v39i1.4029</Citation><ArticleIdList><ArticleId IdType="doi">10.7705/biomedica.v39i1.4029</ArticleId><ArticleId IdType="pubmed">31021550</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucardo F, Reyes Y, Morales M, Brice&#xf1;o R, Gonz&#xe1;lez F, Lundkvist &#xc5;, et al. . Genetic Polymorphisms in DC-SIGN, TLR3 and TNFa Genes and the Lewis-Negative Phenotype Are Associated With Chikungunya Infection and Disease in Nicaragua. J Infect Dis (2020) 2020:jiaa364. &#xa0;10.1093/infdis/jiaa364</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa364</ArticleId><ArticleId IdType="pubmed">33535235</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu SS, Chakraborty TT, Kumar N, Banerjee I. Association Between IFITM3 Rs12252 Polymorphism and Influenza Susceptibility and Severity: A Meta-Analysi. Gene (2018) 674:70&#x2013;9. &#xa0;10.1016/j.gene.2018.06.070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.06.070</ArticleId><ArticleId IdType="pubmed">29940276</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Z, Zhou J, To KK, Chu H, Li C, Wang D, et al. . Identification of TMPRSS2 as a Susceptibility Gene for Severe 2009 Pandemic A(H1N1) Influenza and A(H7N9) Influenza. J Infect Dis (2015) 212:1214&#x2013;21. &#xa0;10.1093/infdis/jiv246</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv246</ArticleId><ArticleId IdType="pmc">PMC7107393</ArticleId><ArticleId IdType="pubmed">25904605</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard A, Uyeki TM, Fergie J. Influenza-Associated Acute Necrotizing Encephalopathy in Siblings. J Pediatr Infect Dis Soc (2018) 7:e172&#x2013;7. &#xa0;10.1093/jpids/piy033</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/piy033</ArticleId><ArticleId IdType="pmc">PMC6636323</ArticleId><ArticleId IdType="pubmed">29741717</ArticleId></ArticleIdList></Reference><Reference><Citation>Languon S, Quaye O. Filovirus Disease Outbreaks: A Chronological Overview. Virol (Auckl) (2019) 10:1178122X19849927. &#xa0;10.1177/1178122X19849927</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1178122X19849927</ArticleId><ArticleId IdType="pmc">PMC6589952</ArticleId><ArticleId IdType="pubmed">31258326</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogoch II, Creatore MI, Cetron MS, Brownstein JS, Pesik N, Miniota J, et al. . Assessment of the Potential for International Dissemination of Ebola Virus Via Commercial Air Travel During the 2014 West African Outbreak. Lancet (2015) 385:29&#x2013;35. &#xa0;10.1016/S0140-6736(14)61828-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61828-6</ArticleId><ArticleId IdType="pmc">PMC4286618</ArticleId><ArticleId IdType="pubmed">25458732</ArticleId></ArticleIdList></Reference><Reference><Citation>Vetter P, Fischer WA, 2nd, Schibler M, Jacobs M, Bausch DG, Kaiser L. Ebola Virus Shedding and Transmission: Review of Current Evidence. J Infect Dis (2016) 214(Suppl 3):S177&#x2013;84. &#xa0;10.1093/infdis/jiw254</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw254</ArticleId><ArticleId IdType="pmc">PMC6283352</ArticleId><ArticleId IdType="pubmed">27443613</ArticleId></ArticleIdList></Reference><Reference><Citation>Victory KR, Coronado F, Ifono SO, Soropogui T, Dahl BA. Ebola Transmission Linked to a Single Traditional Funeral Ceremony &#x2014; Kissidougou, Guinea, December, 2014&#x2013;January 2015. MMWR Morb Mortal Wkly Rep (2015) 64:386&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779538</ArticleId><ArticleId IdType="pubmed">25879897</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster RG. Wet Markets&#x2014;A Continuing Source of Severe Acute Respiratory Syndrome and Influenza? Lancet (2004) 363:234&#x2013;6. &#xa0;10.1016/S0140-6736(03)15329-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)15329-9</ArticleId><ArticleId IdType="pmc">PMC7112390</ArticleId><ArticleId IdType="pubmed">14738798</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KD, Yang MY, Li CC, Lin SF, Chong MC, Wang CL, et al. . Altered Cellular But Not Humoral Reactions in Children With Complicated Enterovirus 71 Infections in Taiwan. J Infect Dis (2001) 183:850&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237800</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CC, Yang MY, Chen RF, Lin TY, Tsao KC, Ning HC, et al. . Clinical Manifestations and Laboratory Assessment in an Enterovirus 71 Outbreak in Southern Taiwan. Scand J Infect Dis (2002) 34:104&#x2013;9. &#xa0;10.1080/00365540110077119</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365540110077119</ArticleId><ArticleId IdType="pubmed">11928838</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. Different Proinflammatory Reactions in Fatal and Non-Fatal Enterovirus 71 Infections: Implications for Early Recognition and Therapy. Acta Paediatr (2002) 91(6):632&#x2013;5. &#xa0;10.1080/080352502760069016</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/080352502760069016</ArticleId><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated Glycans as Receptor and Inhibitor of Enterovirus 71 Infection to DLD-1 Intestinal Cells. Virol J (2009) 6:141. &#xa0;10.1186/1743-422X-6-141</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KD, Yeh WT, Yang MY, Chen RF, Shaio MF. Antibody-Dependent Enhancement of Heterotypic Dengue Infections Involved in Suppression of IFNgamma Production. J Med Virol (2001) 63:150&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170052</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JW, Lee IK, Wang L, Chen RF, Yang KD. The Usefulness of Clinical-Practice-Based Laboratory Data in Facilitating the Diagnosis of Dengue Illness. Biomed Res Int (2013) 2013:198797. &#xa0;10.1155/2013/198797</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/198797</ArticleId><ArticleId IdType="pmc">PMC3881659</ArticleId><ArticleId IdType="pubmed">24455678</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Liu JW, Yang KD. Fatal Dengue Hemorrhagic Fever in Adults: Emphasizing the Evolutionary Pre-Fatal Clinical and Laboratory Manifestations. PloS Negl Trop Dis (2012) 6:e1532. &#xa0;10.1371/journal.pntd.0001532</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001532</ArticleId><ArticleId IdType="pmc">PMC3283557</ArticleId><ArticleId IdType="pubmed">22363829</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD. Implications of Previous Subclinical Dengue Infection But Not Virus Load in Dengue Hemorrhagic Fever. FEMS Immunol Med Microbiol (2006) 48:84&#x2013;90. &#xa0;10.1111/j.1574-695X.2006.00127.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2006.00127.x</ArticleId><ArticleId IdType="pubmed">16965355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, Wang L, Cheng JT, Yang KD. Induction of Ifn&#x3b1; or IL-12 Depends on Differentiation of THP-1 Cells in Dengue Infections Without and With Antibody Enhancement. BMC Infect Dis (2012) 12:340. &#xa0;10.1186/1471-2334-12-340</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-12-340</ArticleId><ArticleId IdType="pmc">PMC3575308</ArticleId><ArticleId IdType="pubmed">23216989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Hsieh CJ, Chen RF, Yang ZS, Wang L, Chen CM, et al. . Increased Production of Interleukin-4, Interleukin-10, and Granulocyte-Macrophage Colony-Stimulating Factor by Type 2 Diabetes&#x2019; Mononuclear Cells Infected With Dengue Virus, But Not Increased Intracellular Viral Multiplication. Biomed Res Int (2013) 2013:965853. &#xa0;10.1155/2013/965853</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/965853</ArticleId><ArticleId IdType="pmc">PMC3773921</ArticleId><ArticleId IdType="pubmed">24078930</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Liu JW, Yang KD. Clinical Characteristics and Risk Factors for Concurrent Bacteremia in Adults With Dengue Hemorrhagic Fever. Am J Trop Med Hyg (2005) 72:221&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15741560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Liu JW, Yang KD. Clinical and Laboratory Characteristics and Risk Factors for Fatality in Elderly Patients With Dengue Hemorrhagic Fever. Am J Trop Med Hyg (2008) 79:149&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">18689614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Chen RF, Liu JW, Yeh WT, Chang JC, Eng HL, et al. . Altered P38 Mitogen-Activated Protein Kinase Expression in Different Leukocytes With Increment of Immunosuppressive Mediators in Patients With Severe Acute Respiratory Syndrome. J Immunol (2004) 172:7841&#x2013;7. &#xa0;10.1016/j.micinf.2005.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2005.06.007</ArticleId><ArticleId IdType="pubmed">15187168</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YS, Chen CH, Chao A, Chen ES, Wei ML, Chen LK, et al. . Molecular Signature of Clinical Severity in Recovering Patients With Severe Acute Respiratory Syndrome Coronavirus (SARS-Co). BMC Genomics (2005) 6:132. &#xa0;10.1186/1471-2164-6-132</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-6-132</ArticleId><ArticleId IdType="pmc">PMC1262710</ArticleId><ArticleId IdType="pubmed">16174304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko SF, Lee TY, Huang CC, Cheng YF, Ng SH, Kuo YL, et al. . Severe Acute Respiratory Syndrome: Prognostic Implications of Chest Radiographic Findings in 52 Patients. Radiology (2004) 233:173&#x2013;81. &#xa0;10.1148/radiol.2323031547</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2323031547</ArticleId><ArticleId IdType="pubmed">15273329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen RF, Chang JC, Yeh WT, Lee CH, Liu JW, Eng HL, et al. . Role of Vascular Cell Adhesion Molecules and Leukocyte Apoptosis in the Lymphopenia and Thrombocytopenia of Patients With Severe Acute Respiratory Syndrome (SAR). Microbes Infect (2006) 8:122&#x2013;7. &#xa0;10.1016/j.micinf.2005.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2005.06.007</ArticleId><ArticleId IdType="pmc">PMC7110783</ArticleId><ArticleId IdType="pubmed">16182592</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu TP, Li CC, Wang L, Hsu LW, Eng HL, You HL, et al. . A Surveillance System to Reduce Transmission of Pandemic H1N1 (2009) Influenza in a 2600-Bed Medical Center. PloS One (2012) 7:e32731. &#xa0;10.1371/journal.pone.0032731</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032731</ArticleId><ArticleId IdType="pmc">PMC3302803</ArticleId><ArticleId IdType="pubmed">22427871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee IK, Liu JW, Wang L, Yang KD, Li CC, Eng HL. 2009 Pandemic Influenza A (H1N1): Clinical and Laboratory Characteristics in Pediatric and Adult Patients and in Patients With Pulmonary Involvement. Influenza Other Respir Viruses (2012) 6:e152&#x2013;61. &#xa0;10.1111/j.1750-2659.2012.00410.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-2659.2012.00410.x</ArticleId><ArticleId IdType="pmc">PMC4941712</ArticleId><ArticleId IdType="pubmed">22846046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Chang LS, Lee IK, Tang KS, Li CC, Eng HL, et al. . Clinical Diagnosis of Pandemic A(H1N1) 2009 Influenza in Children With Negative Rapid Influenza Diagnostic Test by Lymphopenia and Lower C-Reactive Protein Levels. Influenza Other Respir Viruses (2014) 8:91&#x2013;8. &#xa0;10.1111/irv.12182</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12182</ArticleId><ArticleId IdType="pmc">PMC4177802</ArticleId><ArticleId IdType="pubmed">24373294</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CC, Wang L, Eng HL, You HL, Chang LS, Tang KS, et al. . Correlation of Pandemic (H1N1) 2009 Viral Load With Disease Severity and Prolonged Viral Shedding in Children. Emerg Infect Dis (2010) 16:1265&#x2013;72. &#xa0;10.3201/eid1608.091918</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1608.091918</ArticleId><ArticleId IdType="pmc">PMC3298297</ArticleId><ArticleId IdType="pubmed">20678321</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses. J Immunol (2003) 170:2797&#x2013;801. &#xa0;10.4049/jimmunol.170.6.2797</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.6.2797</ArticleId><ArticleId IdType="pubmed">12626527</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy EM, Baize S, Lu CY, McCormick JB, Georges AJ, Georges-Courbot MC, et al. . Diagnosis of Ebola Haemorrhagic Fever by RT-PCR in an Epidemic Setting. J Med Virol (2000) 60:463&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10686031</ArticleId></ArticleIdList></Reference><Reference><Citation>Baize S, Leroy EM, Georges-Courbot MC, Capron M, Lansoud-Soukate J, Debr&#xe9; P, et al. . Defective Humoral Responses and Extensive Intravascular Apoptosis Are Associated With Fatal Outcome in Ebola Virus-Infected Patients. Nat Med (1999) 5:423&#x2013;6. &#xa0;10.1038/7422</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/7422</ArticleId><ArticleId IdType="pubmed">10202932</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ. Clinical Virology of Lassa Fever in Hospitalized Patients. J Infect Dis (1987) 155:456&#x2013;64. &#xa0;10.1093/infdis/155.3.456</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/155.3.456</ArticleId><ArticleId IdType="pubmed">3805773</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JP, Cosgriff TM. Hemorrhagic Fever Virus-Induced Changes in Hemostasis and Vascular Biology. Blood Coag Fibrin (2000) 11:461&#x2013;83. &#xa0;10.1097/00001721-200007000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-200007000-00010</ArticleId><ArticleId IdType="pubmed">10937808</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M. A Critical Role for Induced IgM in the Protection Against West Nile Virus Infection. J&#xa0;Exp Med (2003) 198:1853&#x2013;62. &#xa0;10.1084/jem.20031223</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20031223</ArticleId><ArticleId IdType="pmc">PMC2194144</ArticleId><ArticleId IdType="pubmed">14662909</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson AM, Wysocki J, Batlle D. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications. Hypertension (2020) 76:1339&#x2013;49. &#xa0;10.1161/HYPERTENSIONAHA.120.15256</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.120.15256</ArticleId><ArticleId IdType="pmc">PMC7480804</ArticleId><ArticleId IdType="pubmed">32851855</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. . Immunology of COVID-19: Current State of the Science. Immunity (2020) 52:910&#x2013;41. &#xa0;10.1016/j.immuni.2020.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Yang XO. TH17 Responses in Cytokine Storm of COVID-19: An Emerging Target of JAK2 Inhibitor Fedratinib. J Microbiol Immunol Infect (2020) 53:368&#x2013;70. &#xa0;10.1016/j.jmii.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7156211</ArticleId><ArticleId IdType="pubmed">32205092</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. . Marked T Cell Activation, Senescence, Exhaustion and Skewing Towards TH17 in Patients With COVID-19 Pneumonia. Nat Commun (2020) 11:3434. &#xa0;10.1038/s41467-020-17292-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17292-4</ArticleId><ArticleId IdType="pmc">PMC7338513</ArticleId><ArticleId IdType="pubmed">32632085</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris JS, Chu CM, Cheng VCC, Chan KS, Hung IFN, Poon LLM, et al. . Clinical Progression and Viral Load in a Community Outbreak of Coronavirus-Associated SARS Pneumonia: A Prospective Study. Lancet (2003) 361:1767&#x2013;72. &#xa0;10.1016/s0140-6736(03)13412-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(03)13412-5</ArticleId><ArticleId IdType="pmc">PMC7112410</ArticleId><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf6;lfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, M&#xfc;ller MA, et al. . Virological Assessment of Hospitalized Patients With COVID-2019. Nature (2020) 581:465&#x2013;9. &#xa0;10.1038/s41586-020-2196-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2196-x</ArticleId><ArticleId IdType="pubmed">32235945</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann D, Sperhake JP, L&#xfc;tgehetmann M, Steurer S, Edler C, Heinemann A, et al. . Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med (2020) 173:268&#x2013;77. &#xa0;10.7326/M20-2003</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. . Lung Pathology of Fatal Severe Acute Respiratory Syndrome. Lancet (2003) 361:1773&#x2013;8. &#xa0;10.1016/s0140-6736(03)13413-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(03)13413-7</ArticleId><ArticleId IdType="pmc">PMC7112492</ArticleId><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference><Reference><Citation>Merrill JT, Erkan D, Winakur J, James JA. Emerging Evidence of a COVID-19 Thrombotic Syndrome has Treatment Implications. Nat Rev Rheumatol (2020) 16:581&#x2013;9. &#xa0;10.1038/s41584-020-0474-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0474-5</ArticleId><ArticleId IdType="pmc">PMC7391481</ArticleId><ArticleId IdType="pubmed">32733003</ArticleId></ArticleIdList></Reference><Reference><Citation>Meftahi GH, Jangravi, Sahraei H, Bahari Z. The Possible Pathophysiology Mechanism of Cytokine Storm in Elderly Adults With COVID-19 Infection: The Contribution of &#x201c;Inflame-Aging&#x201d;. Inflamm Res (2020) 69:825&#x2013;89. &#xa0;10.1007/s00011-020-01372-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01372-8</ArticleId><ArticleId IdType="pmc">PMC7289226</ArticleId><ArticleId IdType="pubmed">32529477</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . Update 49 - SARS Case Fatality Ratio, Incubation Period. Available at: https://www.who.int/csr/sarsarchive/2003_05_07a/en/.</Citation></Reference><Reference><Citation>Reilev M, Kristensen KB, Pottegaard A. Characteristics and Predictors of Hospitalization and Death in the First 11,122 Cases With a Positive RT-PCR Test for SARS-CoV-2 in Denmark: A Nationwide Cohort. Int J Epidemiol (2020) 49:1468&#x2013;81. &#xa0;10.1093/ije/dyaa140</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyaa140</ArticleId><ArticleId IdType="pmc">PMC7499657</ArticleId><ArticleId IdType="pubmed">32887982</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E, Walker AJ, Bhaskaran KJ. Factors Associated With COVID-19-Related Death Using OpenSAFELY. Nature (2020) 584:430&#x2013;6. &#xa0;10.1016/j.micinf.2005.06.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2005.06.032</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, et al. . Activation of T Lymphocytes in Dengue Virus Infections. High Levels of Soluble Interleukin 2 Receptor, Soluble CD4, Soluble CD8, Interleukin 2, and Interferon-Gamma in Sera of Children With Dengue. J Clin Invest (1991) 88:1473&#x2013;80. &#xa0;10.1172/JCI115457</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI115457</ArticleId><ArticleId IdType="pmc">PMC295652</ArticleId><ArticleId IdType="pubmed">1939640</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaiboullina SF, St Jeor SC. Hantavirus Immunology. Viral Immunol (2002) 15:609&#x2013;25. &#xa0;10.1089/088282402320914548</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/088282402320914548</ArticleId><ArticleId IdType="pubmed">12513931</ArticleId></ArticleIdList></Reference><Reference><Citation>To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, et al. . Pathology of Fatal Human Infection Associated With Avian Influenza A H5N1 Virus. J&#xa0;Med Virol (2001) 63:242&#x2013;6. &#xa0;10.1002/1096-9071(200103)63:3&lt;242::aid-jmv1007&gt;3.0.co;2-n</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(200103)63:3&lt;242::aid-jmv1007&gt;3.0.co;2-n</ArticleId><ArticleId IdType="pubmed">11170064</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TNB, et al. . Fatal Outcome of Human Influenza A (H5N1) Is Associated With High Viral Load and Hypercytokinemia. Nat Med (2006) 12:1203&#x2013;7. &#xa0;10.1038/nm1477</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1477</ArticleId><ArticleId IdType="pmc">PMC4333202</ArticleId><ArticleId IdType="pubmed">16964257</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaiboullina SF, Levis S, Morzunov SP, Martynova EV, Anokhin VA, Gusev OA, et al. . Serum Cytokine Profiles Differentiating Hemorrhagic Fever With Renal Syndrome and Hantavirus Pulmonary Syndrome. Front Immunol (2017) 8:567. &#xa0;10.3389/fimmu.2017.00567</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00567</ArticleId><ArticleId IdType="pmc">PMC5435745</ArticleId><ArticleId IdType="pubmed">28572804</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . Review of Latest Available Evidence on Potential Transmission of Avian Influenza (lrm;H5N1)lrm; Through Water and Sewage and Ways to Reduce the Risks to Human Health. Available at: https://apps.who.int/iris/handle/10665/204275.</Citation></Reference><Reference><Citation>Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the Eye of the Cytokine Storm. Microbiol Mol Biol Rev (2012) 76:16&#x2013;32. &#xa0;10.1128/MMBR.05015-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.05015-11</ArticleId><ArticleId IdType="pmc">PMC3294426</ArticleId><ArticleId IdType="pubmed">22390970</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavrilovskaya I, Gorbunova E, Koster F, Mackow E. Elevated VEGF Levels in Pulmonary Edema Fluid and PBMCs From Patients With Acute Hantavirus Pulmonary Syndrome. Adv Virol (2012) 2012:674360. &#xa0;10.1155/2012/674360</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/674360</ArticleId><ArticleId IdType="pmc">PMC3432326</ArticleId><ArticleId IdType="pubmed">22956954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kongsomboon K, Singhasivanon P, Kaewkungwal J, Nimmannitya S, Mammen MP, Jr., Nisalak A, et al. . Temporal Trends of Dengue Fever/Dengue Hemorrhagic Fever in Bangkok, Thailand From 1981 to 2000: An Age-Period-Cohort Analysis. Southeast Asian J Trop Med Public Health (2004) 35:913&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15916090</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh RM, Selin LK, Szomolanyi-Tsuda E. Immunological Memory to Viral Infections. Ann Rev Immunol (2004) 22:711&#x2013;43. &#xa0;10.1146/annurev.immunol.22.012703.104527</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.22.012703.104527</ArticleId><ArticleId IdType="pubmed">15032594</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi UC, Agarwal R, Elbishbishi EA, Mustafa AS. Cytokine Cascade in Dengue Hemorrhagic Fever: Implications for Pathogenesis. FEMS Immunol Med Microbiol (2000) 28:183&#x2013;8. &#xa0;10.1111/j.1574-695X.2000.tb01474.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2000.tb01474.x</ArticleId><ArticleId IdType="pubmed">10865168</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingam S, Lidbury BA. Suppression of Lipopolysaccharide-Induced Antiviral Transcription Factor (STAT-1 and NF-Kappa B) Complexes by Antibody-Dependent Enhancement of Macrophage Infection by Ross River Virus. Proc Natl Acad Sci U S A (2002) 99:13819&#x2013;24. &#xa0;10.1073/pnas.202415999</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.202415999</ArticleId><ArticleId IdType="pmc">PMC129781</ArticleId><ArticleId IdType="pubmed">12364588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich H, Pillat MM, T&#xe1;rnok A. Dengue Fever, COVID-19 (Sars-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective. Cytometry A (2020) 97:662&#x2013;7. &#xa0;10.1002/cyto.a.24047</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.24047</ArticleId><ArticleId IdType="pmc">PMC7300451</ArticleId><ArticleId IdType="pubmed">32506725</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al. . The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell (2020) 182:685&#x2013;712.e19. &#xa0;10.1016/j.cell.2020.06.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. . The Immunology of Multisystem Inflammatory Syndrome in Children With COVID-19. Cell (2020) 183:1&#x2013;14. &#xa0;10.1016/j.cell.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu L, Ye F, Feng Y, Yu F, Wang Q, Wu Y, et al. . Both Boceprevir and GC376 Efficaciously Inhibit SARS-CoV-2 by Targeting Its Main Protease. Nat Commun (2020) 11:4417. &#xa0;10.1038/s41467-020-18233-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18233-x</ArticleId><ArticleId IdType="pmc">PMC7474075</ArticleId><ArticleId IdType="pubmed">32887884</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulangu S, Dodd LE, Davey RT, Jr, Tshiani Mbaya O, Proschan M, Mukadi D, et al. . A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. N Engl J Med (2019) 381:2293&#x2013;303. &#xa0;10.1056/NEJMoa1910993</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1910993</ArticleId><ArticleId IdType="pubmed">31774950</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MHL, et al. . Use of&#xa0;Convalescent Plasma Therapy in SARS Patients in Hong Kong. Eu J Clin Microbiol Infect Dis (2005) 24:44&#x2013;6. &#xa0;10.1007/s10096-004-1271-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-004-1271-9</ArticleId><ArticleId IdType="pmc">PMC7088355</ArticleId><ArticleId IdType="pubmed">15616839</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Hajeer AH, Luke T, Raviprakash K, Balkhy H, Johani S, et al. . Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. Emerging Infect Dis (2016) 22:1554&#x2013;61. &#xa0;10.3201/eid2209.151164</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2209.151164</ArticleId><ArticleId IdType="pmc">PMC4994343</ArticleId><ArticleId IdType="pubmed">27532807</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Han M, Li T, Sun W, Wang D, Fu B, et al. . Effective Treatment of Severe COVID-19 Patients With Tocilizumab. Proc Natl Acad Sci U S A (2020) 117:10970&#x2013;5. &#xa0;10.1073/pnas.2005615117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2005615117</ArticleId><ArticleId IdType="pmc">PMC7245089</ArticleId><ArticleId IdType="pubmed">32350134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasonov E, Samsonov M. The Role of Interleukin 6 Inhibitors in Therapy of Severe COVID-19. Biomed Pharmacother (2020) 131:110698. &#xa0;10.1016/j.biopha.2020.110698</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110698</ArticleId><ArticleId IdType="pmc">PMC7455113</ArticleId><ArticleId IdType="pubmed">32920514</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvelli J, Demaria O, V&#xe9;ly F, Batista L, Chouaki Benmansour N, Fares J, et al. . Association of COVID-19 Inflammation With Activation of the C5a-C5aR1 Axis. Nature (2020) 588:146&#x2013;50. &#xa0;10.1038/s41586-020-2600-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2600-6</ArticleId><ArticleId IdType="pmc">PMC7116884</ArticleId><ArticleId IdType="pubmed">32726800</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto A, Nakazawa Y, Ishii E. 016. Hemophagocytic Lymphohistiocytosis: Pathogenesis, Diagnosis, and Management. Pediatr Int 58:817&#x2013;25. &#xa0;10.1111/ped.13064</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.13064</ArticleId><ArticleId IdType="pubmed">27289085</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D, Sharif K, O&#x2019;Regan A, Bridgewood C. The Role of Cytokines Including Interleukin-6 in COVID-19 Induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev (2020) 19:102537. &#xa0;10.1016/j.autrev.2020.102537</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102537</ArticleId><ArticleId IdType="pmc">PMC7195002</ArticleId><ArticleId IdType="pubmed">32251717</ArticleId></ArticleIdList></Reference><Reference><Citation>Boisen ML, Hartnett JN, Shaffer JG, Goba A, Momoh M, Sandi JD, et al. . Field Validation of Recombinant Antigen Immunoassays for Diagnosis of Lassa Fever. Sci Rep (2018) 8:5939. &#xa0;10.1038/s41598-018-24246-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24246-w</ArticleId><ArticleId IdType="pmc">PMC5897328</ArticleId><ArticleId IdType="pubmed">29651117</ArticleId></ArticleIdList></Reference><Reference><Citation>Takah NF, Brangel P, Shrestha P, Peeling R. Sensitivity and Specificity of Diagnostic Tests for Lassa Fever: A Systematic Review. BMC Infect Dis (2019) 19:647. &#xa0;10.1186/s12879-019-4242-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4242-6</ArticleId><ArticleId IdType="pmc">PMC6642489</ArticleId><ArticleId IdType="pubmed">31324229</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, et al. . Lassa Fever. Effective Therapy With Ribavirin. N Engl J Med (1986) 314:20&#x2013;6. &#xa0;10.1056/NEJM198601023140104</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198601023140104</ArticleId><ArticleId IdType="pubmed">3940312</ArticleId></ArticleIdList></Reference><Reference><Citation>Frame JD, Verbrugge GP, Gill RG, Pinneo L. The Use of Lassa Fever Convalescent Plasma in Nigeria. Trans R Soc Trop Med Hyg 78:319&#x2013;24. &#xa0;10.1016/0035-9203(84)90107-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0035-9203(84)90107-x</ArticleId><ArticleId IdType="pubmed">6464130</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob ST, Crozier I, Fischer WA, 2nd, Hewlett A, Kraft CS, Vega MA, et al. . Ebola Virus Disease. Nat Rev Dis Primers (2020) 6:13. &#xa0;10.1038/s41572-020-0147-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0147-3</ArticleId><ArticleId IdType="pmc">PMC7223853</ArticleId><ArticleId IdType="pubmed">32080199</ArticleId></ArticleIdList></Reference><Reference><Citation>Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, et al. . Efficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results From the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola &#xc7;a Suffi)! Lancet (2017) 389:505&#x2013;18. &#xa0;10.1016/S0140-6736(16)32621-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)32621-6</ArticleId><ArticleId IdType="pmc">PMC5364328</ArticleId><ArticleId IdType="pubmed">28017403</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. . Regn-COV2, A Neutralizing Antibody Cocktail, in Outpatients With Covid-19. N Engl J Med (2021) 384(3):238&#x2013;51. &#xa0;10.1056/NEJMoa2035002</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035002</ArticleId><ArticleId IdType="pmc">PMC7781102</ArticleId><ArticleId IdType="pubmed">33332778</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC . Interim Guidance for Antigen Testing for SARS-CoV-2. Retrieved on May 25, 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html.</Citation></Reference><Reference><Citation>Brown RA, Murthy J, Manian P, Rumbaoa B, Connolly T. An Early Aggressive Strategy for the Treatment of Hanta Virus Cardiopulmonary Syndrome: A Perspective From an Extracorporeal Membrane Oxygenation Center. Clin Infect Dis (2014) 59:458&#x2013;9. &#xa0;10.1093/cid/ciu295</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu295</ArticleId><ArticleId IdType="pubmed">24771336</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaheri A, Strandin T, J&#xe4;&#xe4;skel&#xe4;inen AJ, Vapalahti O, Jarva H, Lokki M, et al. . Pathophysiology of a Severe Case of Puumala Hantavirus Infection Successfully Treated With Bradykinin Receptor Antagonist Icatibant. Antiviral Res (2014) 111:23&#x2013;5. &#xa0;10.1016/j.antiviral.2014.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2014.08.007</ArticleId><ArticleId IdType="pubmed">25194993</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JP, Viswanathan S, Wang M, Sun LQ, Clark GC, D&#x2019;Elia RV. Current and Future Developments in the Treatment of Virus-Induced Hypercytokinemia. Future Med Chem (2017) 9:169&#x2013;78. &#xa0;10.4155/fmc-2016-0181</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc-2016-0181</ArticleId><ArticleId IdType="pmc">PMC7079716</ArticleId><ArticleId IdType="pubmed">28128003</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley LF, Wohlford GF, Ting C, Alahmed A, Van Tassell BW, Abbate A, et al. . Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019. Crit Care Explor (2020) 2:e0178. &#xa0;10.1097/CCE.0000000000000178</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000178</ArticleId><ArticleId IdType="pmc">PMC7419062</ArticleId><ArticleId IdType="pubmed">32832913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghi A, Tahmasebi S, Mahmood A, Kuznetsova M, Valizadeh H, Nazemiyeh M, et al. . Th17 and T Reg Cells Function in SARS-CoV2 Patients Compared With Healthy Controls. J Cell Physiol (2020). &#xa0;10.1002/jcp.30047</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30047</ArticleId><ArticleId IdType="pubmed">32926425</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudice V, Pagliano P, Vatrella A, Masullo A, Poto S, Polverino BM, et al. . Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study. Front Pharmacol (2020) 11:857. &#xa0;10.3389/fphar.2020.00857</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.00857</ArticleId><ArticleId IdType="pmc">PMC7291857</ArticleId><ArticleId IdType="pubmed">32581810</ArticleId></ArticleIdList></Reference><Reference><Citation>Streng AS, Delnoij TSR, Mulder MMG, Sels JWEM, Wetzels RJH, Verhezen PWM, et al. . Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO. TH Open (2020) 4:e365&#x2013;75. &#xa0;10.1055/s-0040-1719083</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1719083</ArticleId><ArticleId IdType="pmc">PMC7676995</ArticleId><ArticleId IdType="pubmed">33235946</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando M, Miyazaki E, Hiroshige S, Ashihara Y, Okubo T, Ueo M, et al. . Virus Associated Hemophagocytic Syndrome Accompanied by Acute Respiratory Failure Caused by Influenza A (H3n2). Intern Med (2006) 45:1183&#x2013;6. &#xa0;10.2169/internalmedicine.45.1736</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.45.1736</ArticleId><ArticleId IdType="pubmed">17106167</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo H, Miyamura T, Takahama S, Sonomoto K, Nakamura M, Lumbreras C. Influenza-Associated Hemophagocytic Syndrome in Adults: Case Report and Review. J Antivir Antiretrovir (2018) 10:1&#x2013;5. &#xa0;10.4172/1948-5964.1000172</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/1948-5964.1000172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil AC, Thomas PG. Influenza Virus-Related Critical Illness: Pathophysiology and Epidemiology. Crit Care (2019) 23:258. &#xa0;10.1186/s13054-019-2539-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2539-x</ArticleId><ArticleId IdType="pmc">PMC6642581</ArticleId><ArticleId IdType="pubmed">31324202</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang KD. A Stepwise Infection and Immunity Strategies to Prevent and Treat an Emerging Infection. Am J Biomed Sci Res (2020) 11:AJBSR.MS.ID.001602. &#xa0;10.34297/AJBSR.2020.11.001602</Citation><ArticleIdList><ArticleId IdType="doi">10.34297/AJBSR.2020.11.001602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ollmann Saphire E. A Vaccine Against Ebola Virus. Cell (2020) 181:6. &#xa0;10.1016/j.cell.2020.03.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.011</ArticleId><ArticleId IdType="pubmed">32243796</ArticleId></ArticleIdList></Reference><Reference><Citation>Suschak JJ, Schmaljohn CS. Vaccines Against Ebola Virus and Marburg Virus: Recent Advances and Promising Candidates. Hum Vaccin Immunother (2019) 15:2359&#x2013;77. &#xa0;10.1080/21645515.2019.1651140</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2019.1651140</ArticleId><ArticleId IdType="pmc">PMC6816442</ArticleId><ArticleId IdType="pubmed">31589088</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardi N, Hogan MJ, Weissman D. Recent Advances in mRNA Vaccine Technology. Curr Opin Immunol (2020) 65:14&#x2013;20. &#xa0;10.1016/j.coi.2020.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2020.01.008</ArticleId><ArticleId IdType="pubmed">32244193</ArticleId></ArticleIdList></Reference><Reference><Citation>van Riel D, de Wit E. Next-Generation Vaccine Platforms for COVID-19. Nat Materials (2020) 19:810&#x2013;2. &#xa0;10.1038/s41563-020-0746-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41563-020-0746-0</ArticleId><ArticleId IdType="pubmed">32704139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo SC, Shih SM, Chien LH, Hsiung CA. Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan. Emerg Infect Dis (2020) 26(8):1928&#x2013;30. &#xa0;10.3201/eid2608.201192</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.201192</ArticleId><ArticleId IdType="pmc">PMC7392415</ArticleId><ArticleId IdType="pubmed">32339091</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CJ, Chen TC, Kuo SH, Hsieh MH, Chen YH. Severe Complicated Influenza Declined During the Prevention of COVID-19 in Taiwan. Infect Control Hosp Epidemiol (2020) 2020:1&#x2013;2. &#xa0;10.1017/ice.2020.272</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.272</ArticleId><ArticleId IdType="pmc">PMC7287302</ArticleId><ArticleId IdType="pubmed">32489160</ArticleId></ArticleIdList></Reference><Reference><Citation>Totura AL, Bavari S. Broad-Spectrum Coronavirus Antiviral Drug Discovery. Expert Opin Drug Discov (2019) 14:397&#x2013;412. &#xa0;10.1080/17460441.2019.1581171</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17460441.2019.1581171</ArticleId><ArticleId IdType="pmc">PMC7103675</ArticleId><ArticleId IdType="pubmed">30849247</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg E, Parent A, Yang PL, Sattler M, Liu Q, Liu Q, et al. . Repurposing of Kinase Inhibitors for Treatment of COVID-19. Pharm Res (2020) 37:167. &#xa0;10.1007/s11095-020-02851-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11095-020-02851-7</ArticleId><ArticleId IdType="pmc">PMC7417114</ArticleId><ArticleId IdType="pubmed">32778962</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen MS. Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection. N Engl J Med (2021) 384(3):289&#x2013;91. &#xa0;10.1056/NEJMe2034495</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2034495</ArticleId><ArticleId IdType="pmc">PMC7844860</ArticleId><ArticleId IdType="pubmed">33471984</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu STH, Lin HM, Baine I, Wajnberg A, Gumprecht JP, Rahman F, et al. . Convalescent Plasma Treatment of Severe COVID-19: A Propensity Score-Matched Control Study. Nat Med (2020) 26:1708&#x2013;13. &#xa0;10.1038/s41591-020-1088-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1088-9</ArticleId><ArticleId IdType="pubmed">32934372</ArticleId></ArticleIdList></Reference><Reference><Citation>Libster R, P&#xe9;rez Marc G, Wappner D, Coviello S, Bianchi A, Braem V, et al. . Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults. N Engl J Med (2021) 384(7):610&#x2013;8. &#xa0;10.1056/NEJMoa2033700</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2033700</ArticleId><ArticleId IdType="pmc">PMC7793608</ArticleId><ArticleId IdType="pubmed">33406353</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen MR, Kuo HC, Lee YJ, Chi H, Li SC, Lee HC, et al. . Phenotype, Susceptibility, Autoimmunity and Immunotherapy Between Kawasaki Disease (KD) and COVID-19 Associated Multisystem Inflammatory Syndrome in Children (MIS-C). Front Immunol (2021) 12:632890. &#xa0;10.3389/fimmu.2021.632890</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.632890</ArticleId><ArticleId IdType="pmc">PMC7959769</ArticleId><ArticleId IdType="pubmed">33732254</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes JM, Subramanian S, Laird E, Griffin G, Kenny RA. Perspective: Vitamin D Deficiency and COVID-19 Severity - Plausibly Linked by Latitude, Ethnicity, Impacts on Cytokines, ACE2, and Thrombosis. J Intern Med (2020) 289:97&#x2013;115. &#xa0;10.1111/joim.13149</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13149</ArticleId><ArticleId IdType="pmc">PMC7361294</ArticleId><ArticleId IdType="pubmed">32613681</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammad S, Mishra A, Ashraf MZ. Emerging Role of Vitamin D and its Associated Molecules in Pathways Related to Pathogenesis of Thrombosis. Biomolecules (2019) 9:649. &#xa0;10.3390/biom9110649</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom9110649</ArticleId><ArticleId IdType="pmc">PMC6920963</ArticleId><ArticleId IdType="pubmed">31653092</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemark KD, Colenso CK, Toelzer C, Gupta K, Sessions RB, Davidson AD, et al. . Molecular Simulations Suggest Vitamins, Retinoids and Steroids as Ligands Binding the Free Fatty Acid Pocket of SARS-CoV-2 Spike Protein. Angew Chem Int Ed (2020). &#xa0;10.1002/anie.202015639</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202015639</ArticleId><ArticleId IdType="pmc">PMC8013358</ArticleId><ArticleId IdType="pubmed">33469977</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani ML, Shaik-Dasthagirisaheb YB, Tripodi D, Anogeianaki A, Felaco P, Toniato E, et al. . Interrelationship Between Vitamins and Cytokines in Immunity. J Biol Regul Homeost Agents (2010) 24:385&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">21122276</ArticleId></ArticleIdList></Reference><Reference><Citation>Goddek S. Vitamin D3 and K2 and Their Potential Contribution to Reducing the COVID-19 Mortality Rate. Int J Infect Dis (2020) 99:286&#x2013;90. 10.1016/j.ijid.2020.07.080</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.07.080</ArticleId><ArticleId IdType="pmc">PMC7406600</ArticleId><ArticleId IdType="pubmed">32768697</ArticleId></ArticleIdList></Reference><Reference><Citation>Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. . Metabolites Produced by Commensal Bacteria Promote Peripheral Regulatory T-Cell Generation. Nature (2013) 504:451&#x2013;5. 10.1038/nature12726</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12726</ArticleId><ArticleId IdType="pmc">PMC3869884</ArticleId><ArticleId IdType="pubmed">24226773</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>